Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized open-label phase 2 study of preventive doxycycline for erlotinib-associated folliculitis-like rash in relapsed advanced non-small cell lung cancer
2007-002403-41Phase 2Completed
- Sponsor
- Roche
- Start
- Jul 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in non-small cell lung cancer (NSCLC) comparing Preventive doxycycline plus erlotinib with Erlotinib alone (2 arms). Primary endpoint: Occurrence of folliculitis-like eruption during erlotinib treatment. Started Jul 2007; status: completed.
02
Drugs
doxycyclineerlotinib
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on 2007-002403-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002403-41.